|
⚲
|
| Keyboard |
| Michael Bigham | |
|---|---|
| Firm | Carlyle Investment Management LLC |
| Address | 420 Boylston Street, Suite 501 38 Jermyn Street Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Carlyle Investment Management LLC | |||||
| Abingworth BioVentures VII LP | 021-274482 | Promoter | 240.2 M of 400.0 M |
99.9 M | |
| Secure Edi Holdings LLC | 021-230392 | Executive Officer | 13.1 M of 13.1 M |
||
| Avedro Inc | 021-228625 | Director | 13.7 M of 17.6 M |
||
| Paratek Pharmaceuticals Inc | 021-221025 | Executive Officer | 93.0 M of 93.0 M |
||
| Valeritas Inc | 021-158315 | Director | 9.4 M of 10.0 M |
||
| Supernus Pharmaceuticals Inc | 021-154736 | Director | 30.0 M of 30.0 M |
||
| Primeradx Inc | 021-78694 | Director | 19.8 M of 20.0 M |
||
| Avila Therapeutics Inc | 021-117636 | Executive Officer | 22.5 M of 30.0 M |
||